Lucid Diagnostics Inc.LUCDEarnings & Financial Report
Nasdaq
NextMar 24, 2026
LUCD Q3 2025 Key Financial Metrics
Revenue
$1.2M
Gross Profit
N/A
Operating Profit
$-11.8M
Net Profit
$-10.4M
Gross Margin
N/A
Operating Margin
-971.0%
Net Margin
-858.5%
YoY Growth
3.3%
EPS
$-0.10
Financial Flow
Lucid Diagnostics Inc. Q3 2025 Financial Summary
Lucid Diagnostics Inc. reported revenue of $1.2M for Q3 2025, with a net profit of $-10.4M (-858.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.2M |
|---|---|
| Net Profit | $-10.4M |
| Gross Margin | N/A |
| Operating Margin | -971.0% |
| Report Period | Q3 2025 |
Lucid Diagnostics Inc. Annual Revenue by Year
Lucid Diagnostics Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $4.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $4.3M |
| 2023 | $2.4M |
| 2022 | $377.0K |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $1.0M | $976000 | $1.2M | $1.2M | $828000 | $1.2M | $1.2M |
| YoY Growth | 828.6% | 124.4% | 513.8% | 49.7% | 15.1% | -17.3% | 19.2% | 3.3% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $27.3M | $32.0M | $34.1M | $22.6M | $30.7M | $32.8M | $38.7M | $53.2M |
| Liabilities | $29.6M | $20.2M | $18.1M | $16.3M | $25.3M | $38.2M | $30.8M | $27.4M |
| Equity | $-2.3M | $11.9M | $16.0M | $6.3M | $5.4M | $-5.4M | $7.9M | $25.8M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-10.0M | $-12.6M | $-11.5M | $-10.2M | $-9.9M | $-12.5M | $-10.5M | $-10.9M |